Compugen (CGEN) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Compugen (CGEN) PT Lowered to $14 at Truist Securities
February 25, 2022 6:36 AM ESTTruist Securities analyst Asthika Goonewardene lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Following the EPS call and our discussion with mgmt, we are adjusting our model to reflect a slower route... More
Compugen (CGEN) PT Lowered to $14 at Stifel
February 24, 2022 12:17 PM ESTStifel analyst Stephen Willey lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Management continues to make progress on the various dose expansion cohorts comprising the P1/2 development program evaluating various COM701-based combinations... More
